Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Modified Vaccine for High Risk or Low Residual Melanoma Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer
- Status
- TERMINATED
- Phase
- NA
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)
- Status
- COMPLETED
- Phase
- PHASE3
Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial for Large ER-Negative Breast Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3